
TRANSCODE THERAPEUTICS INC
RNAZNASDAQ๐ #3908 by market capEarnings Aug 18US Equity
$3.43โผ $0.40 (โ11.60%)
๐ After hours$3.90โฒ 13.70%Regular close ยท extended-hours price shown1hโ
24hโผ 11.6%
7dโผ 34.7%
14dโผ 28.4%
30dโผ 61.4%
1yโผ 69.8%
๐ฆMarket Cap
$4M
Small Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
โ
Otter Score
49
Weak
Earnings
Q2 ยท 2026Reported 2026-05-15Earnings Per Share
Actual
-21.28
Expected
โ
โ
โ
YoY โ26.60%
Revenue
Actual
โ
Expected
โ
โ
โ
Consensus estimates
Recent quarters
Q2 2026
-21.28
โ
Q2 2026
-16.42
miss
Q4 2025
-5.49
beat
Q3 2025
-4.94
beat